Inamed GmbH

Company

    • Company type:
      • Research & Development
      • Service Provider
    • Year founded:
    • 1998
    • Employees (at the site):
    • 50
    • Turnover range:
    • not available
    • Products/services:
    • Clinical Research

      - Clinical Trials Phase I, IIa, II, III, IV - Design, Performance and Evaluation
      - Consulting / Regulatory Affairs / Recruitment of Study Sites / Project Management / Monitoring / Data Management / Biometrics / Statistics / Medical Writing

      Respiratory CRO
      - Inhalation Research, Aerosol Research

      - Consulting for Device Development / Respiratory Drug Development
      - Scientific-, Medical-, Clinical-, Regulatory Consulting

      -Inhalation Device Testing
      - Aerosol (Device / Drug) Characterization
      - Emitted dose / Particle Size / Flow Dependency /
      - Deposition Modeling

      - Lung Imaging
      - Lung Deposition of Radioactive Labeled Drugs / Lung Scintigraphy Studies
      (radio labeling of: liquids, MDIs, dry powders)
      - Investigation of Mucociliary Clearance

      - Drug Targeting Studies
      - Bioequivalence / Pharmacokinetic / Pharmacodynamic Trials

    • Core competencies:
    • Inamed: CRO and international partner to develop drugs for respiratory diseases, inhalation devices, and inhaled drugs.

      Sound experience conducting Phase I-IV clinical trials delivering the highest quality data.

      Inamed’s expertise and unique spectrum of services include an in-house PH I unit, in-vitro labs, radio-labelling facilities.

    • Language skills:
    • English
      French
      German
      Spanish
    • Key Tech / section:
      • Biotechnology: Contract research (CROs) and contract manufacturing (CMOs)
      • Biotechnology: Prophylactic drug development
      • Biotechnology: Therapeutic drug development
      • Medical Technology: Anesthesia, respiration, resuscitation
      • Medical Technology: Medical and electro-medical instruments and devices
    • Certification:
    • not available

    • Sales markets - target industries:
    • Pharmaceutical Industry, Biotech Companies, Medical device Industry, Medical Gas Industry, Start-ups, CROs
    • Sales markets - target countries:
      • Austria
      • Belgium
      • Bulgaria
      • Canada
      • Denmark
      • Estonia
      • Finland
      • France
      • Germany
      • Ireland
      • Italy
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Romania
      • Spain
      • Sweden
      • Switzerland
      • United Kingdom
      • United States
    • Cooperation offers:
    • not available
    • Contact person:
    • Patrick McManus (Mr.)
      - Sales / marketing
      - Cooperation

      Dr. Matthias Heil (Mr.)
      - Management
      - Research & development